Abstract
An analysis is presented of data collected to evaluate the impact of a clinical pharmacy service on an acute psychiatric admitting unit. Retrospective longitudinal drug utilization reviews (RLDUR) were performed one year apart (pre- and post-implementation of services) on the same treatment team. Process measures significantly affected include (percent reduction): total drugs/patient (33.9), number of antipsychotic drugs/patient (38.0), number of anticholinergic started on admission/patient (53.2), and number of doses/patient/d (42.4). Other drug-use parameters significantly affected include: a 42-percent increase in the mean dosage expressed as chlorpromazine equivalents, and a 47-percent reduction in the number of patients on low potency antipsychotic medications. Beneficial outcome was reflected by a faster rate of discharge or transfer to a less restrictive ward environment in the pharmacy study population. The study population also demonstrated a 55.8-percent decrease in their readmission rate to the facility over a one-year follow-up period. Clinical pharmacy services positively affect both process and outcome health care measures.
| Original language | English |
|---|---|
| Pages (from-to) | 632-634 |
| Number of pages | 3 |
| Journal | Drug Intelligence and Clinical Pharmacy |
| Volume | 18 |
| Issue number | 7-8 |
| DOIs | |
| State | Published - 1 Jan 1984 |
Fingerprint
Cite this
}
Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility. / Saklad, S. R.; Ereshefsky, L.; Jann, Michael Wong; Crismon, M. L.
In: Drug Intelligence and Clinical Pharmacy, Vol. 18, No. 7-8, 01.01.1984, p. 632-634.Research output: Contribution to journal › Article
TY - JOUR
T1 - Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility
AU - Saklad, S. R.
AU - Ereshefsky, L.
AU - Jann, Michael Wong
AU - Crismon, M. L.
PY - 1984/1/1
Y1 - 1984/1/1
N2 - An analysis is presented of data collected to evaluate the impact of a clinical pharmacy service on an acute psychiatric admitting unit. Retrospective longitudinal drug utilization reviews (RLDUR) were performed one year apart (pre- and post-implementation of services) on the same treatment team. Process measures significantly affected include (percent reduction): total drugs/patient (33.9), number of antipsychotic drugs/patient (38.0), number of anticholinergic started on admission/patient (53.2), and number of doses/patient/d (42.4). Other drug-use parameters significantly affected include: a 42-percent increase in the mean dosage expressed as chlorpromazine equivalents, and a 47-percent reduction in the number of patients on low potency antipsychotic medications. Beneficial outcome was reflected by a faster rate of discharge or transfer to a less restrictive ward environment in the pharmacy study population. The study population also demonstrated a 55.8-percent decrease in their readmission rate to the facility over a one-year follow-up period. Clinical pharmacy services positively affect both process and outcome health care measures.
AB - An analysis is presented of data collected to evaluate the impact of a clinical pharmacy service on an acute psychiatric admitting unit. Retrospective longitudinal drug utilization reviews (RLDUR) were performed one year apart (pre- and post-implementation of services) on the same treatment team. Process measures significantly affected include (percent reduction): total drugs/patient (33.9), number of antipsychotic drugs/patient (38.0), number of anticholinergic started on admission/patient (53.2), and number of doses/patient/d (42.4). Other drug-use parameters significantly affected include: a 42-percent increase in the mean dosage expressed as chlorpromazine equivalents, and a 47-percent reduction in the number of patients on low potency antipsychotic medications. Beneficial outcome was reflected by a faster rate of discharge or transfer to a less restrictive ward environment in the pharmacy study population. The study population also demonstrated a 55.8-percent decrease in their readmission rate to the facility over a one-year follow-up period. Clinical pharmacy services positively affect both process and outcome health care measures.
UR - http://www.scopus.com/inward/record.url?scp=0021148850&partnerID=8YFLogxK
U2 - 10.1177/106002808401800718
DO - 10.1177/106002808401800718
M3 - Article
C2 - 6745092
AN - SCOPUS:0021148850
VL - 18
SP - 632
EP - 634
JO - Drug Intelligence and Clinical Pharmacy
JF - Drug Intelligence and Clinical Pharmacy
SN - 0012-6578
IS - 7-8
ER -